SNAP reverses temozolomide resistance in human glioblastoma multiforme cells through down‐regulation of MGMT

Nov 15, 2019FASEB journal : official publication of the Federation of American Societies for Experimental Biology

SNAP may reverse drug resistance in human glioblastoma cells by lowering MGMT levels

AI simplified

Abstract

Nitric oxide donor nitroso-acetylpenicillamine (SNAP) may reverse temozolomide resistance in glioblastoma multiforme cells.

  • SNAP demonstrated antitumor effects on both temozolomide-sensitive and temozolomide-resistant glioma cells.
  • It induced cell death, disrupted mitochondrial function, and activated hypoxia-inducing factor 1.
  • SNAP resensitized temozolomide-resistant glioblastoma cells to temozolomide by down-regulating MGMT expression.
  • The mechanism involved post-translational modifications of specific proteins that affect MGMT stability.
  • Combined treatment of SNAP and temozolomide enhanced tumor growth inhibition.

AI simplified

Full Text

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free